Imran Haque, SVP of AI and Digital Sciences at Recursion, joined researchers at the Broad Institute's 2023 Machine Learning in Drug Discovery Symposium to share how Recursion is leveraging petabyte-scale proprietary data to map biology and chemistry and industrialize drug discovery.

Watch the full presentation to explore how we are turning drug discovery into a search problem and revolutionizing the field with a technology-forward approach.

To learn more about our technology, visit https://www.recursion.com/operating-s....

About Recursion:
Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, and chemistry to advance the future of medicine.

Visit https://www.recursion.com/ to learn more.

#biology #chemistry #data #datascience #techbio #drugdiscovery #biotech #biotechnology #healthcare #health #medicine #ai #artificialintelligence #machinelearning #ml